Evidence map›Paper›PMID 40336850›Full record

ArticleWorld journal of nuclear medicine2025

Enhanced Detection of Recurrent Diffuse Malignant Peritoneal Mesothelioma Using

Marwah Abdulrahman, Ula Al-Rasheed, Ali Dabous, Akram Al-Ibraheem

Abstract readCase Reports
In one paragraph

Article in World journal of nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marwah AbdulrahmanDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan.
Ula Al-RasheedDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan.
Ali DabousDepartment of Transplant and Oncosurgery, King Hussein Cancer Center (KHCC), Amman, Jordan.
Akram Al-IbraheemDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan.ORCID 0000-0002-0978-4716

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diffuse malignant peritoneal mesothelioma (DMPM) is a rare and aggressive subtype of epithelioid mesothelioma that arises from the lining of the abdominal cavity. While the applications of traditional fluorine-18 fluorodeoxyglucose (

Indexed as

68 Ga-FAPI PET/CTDMPMFAPIFAPI theranosticsmalignant peritoneal mesothelioma

Identifiers

PMID40336850
PMCPMC12055249

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.